Vallis, K., Reilley, R., Scollard, D., Petronis, J., Caldwell, C., Hendler, A., . . . Oza, A. (2005). A phase I clinical trial to evaluate the pharmacokinetics, toxicity and dosimetry of 111-indium-labeled human epidermal growth factor in patients with metastatic breast cancer.
Style de citation Chicago (17e éd.)Vallis, K., R. Reilley, D. Scollard, J. Petronis, C. Caldwell, A. Hendler, G. Lockwood, et A. Oza. A Phase I Clinical Trial to Evaluate the Pharmacokinetics, Toxicity and Dosimetry of 111-indium-labeled Human Epidermal Growth Factor in Patients with Metastatic Breast Cancer. 2005.
Style de citation MLA (9e éd.)Vallis, K., et al. A Phase I Clinical Trial to Evaluate the Pharmacokinetics, Toxicity and Dosimetry of 111-indium-labeled Human Epidermal Growth Factor in Patients with Metastatic Breast Cancer. 2005.